Geode Capital Management, LLC
- SEC CIK
- 0001214717
- Latest filing
- Aug 12, 2026
ENSC holding history
Ensysce Biosciences, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENSC overviewAll 13F holders of ENSCFull Q2 2026 holdings
- Shares (Q2 2026)
- 62,188
- Value
- $18.0K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 62,188 | $18.0K | <0.1% | −11,692−15.8% | Reduced | Holders |
| Q1 2026 | 73,880 | $39.8K | <0.1% | +51,790+234.4% | Added | Holders |
| Q4 2025 | 22,090 | $20.3K | <0.1% | +9,060+69.5% | Added | Holders |
| Q3 2025 | 13,030 | $30.9K | <0.1% | +2,869+28.2% | Added | Holders |
| Q2 2025 | 10,161 | $22.7K | <0.1% | +10,161 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −46,072−100.0% | Sold out | Holders |
| Q3 2024 | 46,072 | $11.1K | <0.1% | −29−0.1% | Reduced | Holders |
| Q2 2024 | 46,101 | $23.3K | <0.1% | +27,783+151.7% | Added | Holders |
| Q1 2024 | 18,318 | $14.5K | <0.1% | +2,037+12.5% | Added | Holders |
| Q4 2023 | 16,281 | $17.0K | <0.1% | −149−0.9% | Reduced | Holders |
| Q3 2023 | 16,430 | $22.5K | <0.1% | +16,430 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −6,526−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q3 2022 | 130,523 | $28.0K | <0.1% | +3,175+2.5% | Added | Holders |
| Q2 2022 | 127,348 | $110.0K | <0.1% | +17,102+15.5% | Added | Holders |
| Q1 2022 | 110,246 | $125.0K | <0.1% | +9,325+9.2% | Added | Holders |
| Q4 2021 | 100,921 | $474.0K | <0.1% | +45,991+83.7% | Added | Holders |
| Q3 2021 | 54,930 | $166.0K | <0.1% | +54,930 | New | Holders |